Dr. Reddy's Laboratories Limited (ADR) (RDY)
A global pharmaceutical company, which produces pharmaceutical ingredients and intermediates, finished dosage forms and biotechnology products and markets them globally. It conducts research in the areas of cancer, diabetes, cardiovascular disease etc.
Recs
a2investments
(45.20)
Submitted: 11/24/2009 7:49:35 PM :
Start Price:
$24.19
RDY Score:
-1.26
Emerging world-class generic drug company. Underrepresented in most India funds. Ultraconservative S&P gives it five stars. Takeover candidate. Good pipeline. Quality investable midcap.
Recs
stormeywhether
(59.82)
Submitted: 11/22/2009 11:22:38 AM :
Start Price:
$24.06
RDY Score:
-1.14
cheap labor, strong asian market, generic drugs. recently established a discovery lab with plans to develop proprietary drugs
Recs
runyard
(67.05)
Submitted: 11/10/2009 5:48:30 PM :
Start Price:
$20.89
RDY Score:
+10.17
I bought this in real life last fall at about $10, so I'm a happy camper.
Recs
Owley1
(< 20)
Submitted: 11/9/2009 8:34:48 PM :
Start Price:
$23.78
RDY Score:
-1.26
Numbers look excellent
Recs
JudgeJim23
(< 20)
Submitted: 11/4/2009 6:30:35 PM :
Start Price:
$22.96
RDY Score:
-1.19
RDY is capturing a very large share of the generic drug market, worldwide. Revenue, EPS and Guidance are all better than S& P 500.
Recs
Creoena
(< 20)
Submitted: 10/22/2009 11:57:35 AM :
Start Price:
$19.53
RDY Score:
+19.68
View this as a takeover target by a company looking to have pharma development overseas (i.e. lower labor costs). With Obamacare, I think the demand for generics will go up even further, and some company will want to get into the generics business or increase their generic business, and this is a perfect company for takeover for that
Recs
Recs
dancingeorge
(< 20)
Submitted: 8/6/2009 11:20:36 AM :
Start Price:
$16.54
RDY Score:
+32.68
Indian company with world market for Generic drugs that Obama will guarantee multiyear growth. With Teva the class of the sector because of management expertise and cost benefits.. Fda concerns now in ther past Pe going forward ignores huge potential in U.S. alone
Recs
jameshartland
(87.86)
Submitted: 6/7/2009 1:04:59 PM :
Start Price:
$14.09
RDY Score:
+49.92
Indian Pharmaceutical, successful and will grow to become even more successful
Recs
airenInDebt
(50.23)
Submitted: 4/6/2009 1:32:53 PM :
Start Price:
$9.89
RDY Score:
+105.66
Generic pharms still have a lot of growth potential as more and more drug's patents expire
Recs
Trimalerus
(99.66)
Submitted: 3/20/2009 10:51:40 PM :
Start Price:
$8.20
RDY Score:
+149.01
This generic drug manufacturer is based in India so they have relatively low overhead. Also they are located in the area of the world that has 70% of the world's population, which means lots of people needing medications. And being that India & China are relatively poor relative to Europe or the US they really like cheap generic drugs. I'll buy now that the price is about $8 and sell at $16 or so.
Recs
RonChapmanJr
(99.83)
Submitted: 12/19/2008 12:10:29 PM :
Start Price:
$9.96
RDY Score:
+112.72
Good stuff. Medicine is big and will only get bigger.
Recs
yeraz
(86.36)
Submitted: 10/11/2008 9:31:02 PM :
Start Price:
$8.45
RDY Score:
+162.39
Huge generic drugs market in India.
Recs
SCSDogz
(< 20)
Submitted: 9/16/2008 11:33:31 AM :
Start Price:
$11.64
RDY Score:
-108.94
I see bright things for this company in the future. They have a 4 biologics in the pipeline and 3 acquisitions over the last couple years. But these will not bear fruit for a while. Also RDY is still a young global company that needs to deal with growth in a profitable manner, not just for the sake of growth. They will turn to outperformers in about 2-3 years.
Recs
mrsudbury
(98.28)
Submitted: 6/14/2008 8:09:01 PM :
Start Price:
$16.39
RDY Score:
+61.25
seems like a good long term sector favourite with room for upside.
Recs
ak2k8
(90.89)
Submitted: 4/18/2008 11:23:33 AM :
Start Price:
$15.47
RDY Score:
+71.42
Dr.Reddy's is (in)famous for picking up drugs immediately after the patents expire and minting money. They are into generic drugs. with Walmart's $4 drugs, the demand for generic drugs from overseas is high. I wouldn't trust the chinese to give me medicine but Indian Pharma industry is quite well developed. Dr.Reddy's Labs makes good money domestically as well as through exports to Americas and Africa. With generic drugs, cost is the only barrier with no much research required.
Recs
hervren
(65.57)
Submitted: 3/5/2008 5:33:05 PM :
Start Price:
$14.32
RDY Score:
+79.83
india will continue to grow for years
Recs
nealandali
(< 20)
Submitted: 2/23/2008 10:40:52 AM :
Start Price:
$13.42
RDY Score:
+92.66
Generic Drug Maker....Plus research...Need I say more?
Recs
TheBadDad
(70.59)
Submitted: 2/21/2008 9:37:45 PM :
Start Price:
$13.71
RDY Score:
+88.57
RDY has lurched from problem to problem (losing a key lawsuit, collapse of the Indian market) but seems well poised to make a strong comeback from today's level ($13.76).
Recs
21popsontop
(69.63)
Submitted: 2/4/2008 2:07:16 AM :
Start Price:
$13.67
RDY Score:
+91.70
India's growth will only gain more ground in the global markets. This company will be one of its many top performers over time.Has already started paying dividend yield.Just kicked off in september 2007 in the OTC drug market with U.S.,and will be launching several new products in up coming quarters with its massive pipeline of customers worldwide,the potential outlook of growth here is AWESOME! Already has launched authorized generic products simvastatin and finasteride of Merk's zocar,and proscar Just put out a new generic form of PFE's zyrtec and looking to put out a generic form of GSK's imitrex over the next year or so along with many other prospects.Look for this one to make a major impact on the global markets,and is already doing so.FDA has already granted final approval for its new drug application (ANDA) for ranitidine (Zantac) India is still underdeveloped in ways business wise and it will take a little time to work kinks out,but work them out they will as the country's growth moves forward.One to take a hard look at for sure.
RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 1 - 20 of 58 1 2 3 Next »